Event Details

KemPharm® is a rare disease therapeutics company focused on the discovery, development and commercialization of novel treatments for rare CNS and neurodegenerative diseases, lysosomal storage disorders and related treatment areas.

KemPharm Fourth Quarter 2017 Corporate Update Call

Mar 29, 2018 at 4:30 PM EDT